Search details
1.
Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy.
Cell
; 179(5): 1177-1190.e13, 2019 Nov 14.
Article
in English
| MEDLINE | ID: mdl-31730856
2.
Aging-associated and CD4 T-cell-dependent ectopic CXCL13 activation predisposes to anti-PD-1 therapy-induced adverse events.
Proc Natl Acad Sci U S A
; 119(29): e2205378119, 2022 07 19.
Article
in English
| MEDLINE | ID: mdl-35858347
3.
Simultaneous Tumor Shrinkage and Bronchial Perforation Induced by Nivolumab plus Cabozantinib Combination Therapy in a Patient with Collecting Duct Carcinoma.
Chemotherapy
; 69(1): 45-48, 2024.
Article
in English
| MEDLINE | ID: mdl-37820606
4.
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 545-550, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38517658
5.
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(4): 355-362, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38353907
6.
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 2024 Apr 23.
Article
in English
| MEDLINE | ID: mdl-38649648
7.
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 551-558, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38526621
8.
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022.
Int J Clin Oncol
; 29(5): 559-563, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38538963
9.
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38578596
10.
Therapeutic use of granulocyte colony-stimulating factor (G-CSF) in patients with febrile neutropenia: a comprehensive systematic review for clinical practice guidelines for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Int J Clin Oncol
; 2024 May 02.
Article
in English
| MEDLINE | ID: mdl-38696053
11.
Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan.
Cancer Sci
; 114(4): 1710-1717, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36601953
12.
Predictive value of CXCL10 for the occurrence of immune-related adverse events in patient with renal cell carcinoma.
Microbiol Immunol
; 67(7): 345-354, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36975091
13.
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
Gastric Cancer
; 26(1): 132-144, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36316527
14.
Anticancer drug therapy for patients with renal dysfunction.
Int J Clin Oncol
; 28(5): 637-643, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36976431
15.
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma.
Int J Clin Oncol
; 28(3): 416-426, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36595123
16.
Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis.
Int J Clin Oncol
; 28(12): 1651-1658, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37658926
17.
The prevalence of lynch syndrome (DNA mismatch repair protein deficiency) in patients with primary localized prostate cancer using immunohistochemistry screening.
Hered Cancer Clin Pract
; 21(1): 20, 2023 Oct 12.
Article
in English
| MEDLINE | ID: mdl-37828628
18.
Clinical outcomes of nivolumab plus ipilimumab in patients with metastatic non-clear cell renal cell carcinoma: Real-world data from a Japanese multicenter retrospective study.
Int J Urol
; 30(9): 714-721, 2023 09.
Article
in English
| MEDLINE | ID: mdl-36541136
19.
One-year changes in activities of daily living and social life in elderly patients undergoing home-based rehabilitation within 1 year of stroke onset.
J Phys Ther Sci
; 35(10): 689-695, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37791002
20.
Classification of PD-L1 expression in various cancers and macrophages based on immunohistocytological analysis.
Cancer Sci
; 113(9): 3255-3266, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35633190